These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 19271944)

  • 21. Myasthenia gravis: subgroup classification and therapeutic strategies.
    Gilhus NE; Verschuuren JJ
    Lancet Neurol; 2015 Oct; 14(10):1023-36. PubMed ID: 26376969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response to therapy in myasthenia gravis with anti-MuSK antibodies.
    Evoli A; Bianchi MR; Riso R; Minicuci GM; Batocchi AP; Servidei S; Scuderi F; Bartoccioni E
    Ann N Y Acad Sci; 2008; 1132():76-83. PubMed ID: 18567856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Towards antigen-specific apheresis of pathogenic autoantibodies as a further step in the treatment of myasthenia gravis by plasmapheresis.
    Zisimopoulou P; Lagoumintzis G; Kostelidou K; Bitzopoulou K; Kordas G; Trakas N; Poulas K; Tzartos SJ
    J Neuroimmunol; 2008 Sep; 201-202():95-103. PubMed ID: 18667243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ocular myasthenia gravis.
    Gilbert ME; Savino PJ
    Int Ophthalmol Clin; 2007; 47(4):93-103, ix. PubMed ID: 18049283
    [No Abstract]   [Full Text] [Related]  

  • 25. Therapeutic strategies for myasthenia gravis.
    Keys PA; Blume RP
    DICP; 1991 Oct; 25(10):1101-8. PubMed ID: 1803801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myasthenia gravis. Pathogenesis and current concepts in management.
    Havard CW; Scadding GK
    Drugs; 1983 Aug; 26(2):174-84. PubMed ID: 6884241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-musk antibody after thymectomy in a previously seropositive myasthenic child.
    Saulat B; Maertens P; Hamilton WJ; Bassam BA
    Neurology; 2007 Aug; 69(8):803-4. PubMed ID: 17709714
    [No Abstract]   [Full Text] [Related]  

  • 28. [Ocular myasthenia: a diagnostic and management challenge--a review].
    Langmann A; Lindner S; Koch M; Diez J
    Klin Monbl Augenheilkd; 2004 Feb; 221(2):77-86. PubMed ID: 14986204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Classification of myasthenia gravis based on autoantibody status.
    Suzuki S; Utsugisawa K; Nagane Y; Satoh T; Terayama Y; Suzuki N; Kuwana M
    Arch Neurol; 2007 Aug; 64(8):1121-4. PubMed ID: 17698702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Juvenile myasthenia gravis].
    Papazian O; Alfonso I
    Medicina (B Aires); 2009; 69(1 Pt 1):71-83. PubMed ID: 19240004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of autoimmune myasthenia].
    Pénisson-Besnier I
    Rev Neurol (Paris); 2010 Apr; 166(4):400-5. PubMed ID: 19836041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Striational antibodies in myasthenia gravis: reactivity and possible clinical significance.
    Romi F; Skeie GO; Gilhus NE; Aarli JA
    Arch Neurol; 2005 Mar; 62(3):442-6. PubMed ID: 15767509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune regulation in myasthenia gravis: evidence for an increased suppressor T-cell population.
    Miller AE; Hudson J; Tindall RS
    Ann Neurol; 1982 Oct; 12(4):341-7. PubMed ID: 6216848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Use of therapeutic plasmapheresis in patients with generalized myasthenia during exacerbations in the late period following thymectomy].
    Marchuk AI; Golovteev VV; Sapin SM; Shagal DI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(3):330-3. PubMed ID: 3705836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myasthenia gravis: clinical, immunological, and therapeutic advances.
    Romi F; Gilhus NE; Aarli JA
    Acta Neurol Scand; 2005 Feb; 111(2):134-41. PubMed ID: 15644074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment strategies for myasthenia gravis.
    Díaz-Manera J; Rojas-García R; Illa I
    Expert Opin Pharmacother; 2009 Jun; 10(8):1329-42. PubMed ID: 19445561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapy of myasthenia gravis].
    Rilling G; Tettenborn B
    Praxis (Bern 1994); 2001 Aug; 90(33):1350-4. PubMed ID: 11534319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of myasthenia gravis.
    Kumar V; Kaminski HJ
    Curr Neurol Neurosci Rep; 2011 Feb; 11(1):89-96. PubMed ID: 20927659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of myasthenia gravis.
    Saperstein DS; Barohn RJ
    Semin Neurol; 2004 Mar; 24(1):41-8. PubMed ID: 15229791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ocular myasthenia: diagnosis and treatment].
    Stojkovic T; Béhin A
    Rev Neurol (Paris); 2010 Dec; 166(12):987-97. PubMed ID: 21075410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.